Skip to content

May 4, 2026

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
M&A / Deals
Eli Lilly to Acquire Kelonia Therapeutics

M&A / Deals

Eli Lilly to Acquire Kelonia Therapeutics

Big Molecule Watch

On April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc.

Read full story

pharminent May 4, 2026 (Last updated: May 4, 2026)

Big Molecule Watch

On April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc.

Read full story

Post navigation

Previous: Gene therapy’s evidence problem–lessons from recent FDA decisions

Next: 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease

Related Stories

M&A / Deals

UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases

pharminent May 4, 2026

M&A / Deals

LEO Pharma to acquire gene therapy company Replay

pharminent May 1, 2026

M&A / Deals

Two biotechs raise a combined $556M in latest spurt of IPOs

pharminent May 1, 2026

You May Have Missed

Commercial

Odyssey eyes $236M for renewed Nasdaq bid, Seaport docks on Nasdaq

pharminent May 4, 2026

Other

223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease

pharminent May 4, 2026

M&A / Deals

Eli Lilly to Acquire Kelonia Therapeutics

pharminent May 4, 2026

Regulatory

Gene therapy’s evidence problem–lessons from recent FDA decisions

pharminent May 4, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.